Author: ELI LILLY AND COMPANY

Posted Date:

May 18, 2026

Lilly to participate in Bernstein’s 42nd Annual Strategic Decisions Conference

ELI LILLY AND COMPANY

May 18, 2026
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility

ELI LILLY AND COMPANY

May 16, 2026
Lilly and UNICEF collaborate to give millions of children a healthier start

ELI LILLY AND COMPANY

May 14, 2026
Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials

ELI LILLY AND COMPANY

May 13, 2026
In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries

ELI LILLY AND COMPANY

May 12, 2026
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility

ELI LILLY AND COMPANY

May 7, 2026
Lilly’s Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years

ELI LILLY AND COMPANY

May 5, 2026
Lilly declares second-quarter 2026 dividend

ELI LILLY AND COMPANY

May 4, 2026
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

ELI LILLY AND COMPANY

April 30, 2026
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera

ELI LILLY AND COMPANY

April 27, 2026